Guangxi LiuYao Group Co., Ltd (603368.SS)
CNY 18.49
(-0.59%)
CNY 18.49
(-0.59%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 4.42 Billion CNY | 3.86% |
| 2022 | 4.25 Billion CNY | 8.51% |
| 2021 | 3.92 Billion CNY | 7.97% |
| 2020 | 3.63 Billion CNY | 61.28% |
| 2019 | 2.25 Billion CNY | 28.45% |
| 2018 | 1.75 Billion CNY | 181.18% |
| 2017 | 623.67 Million CNY | 137.14% |
| 2016 | 263 Million CNY | -61.39% |
| 2015 | 681.12 Million CNY | 7.32% |
| 2014 | 634.63 Million CNY | 6.59% |
| 2013 | 595.41 Million CNY | 41.05% |
| 2012 | 422.14 Million CNY | 60.2% |
| 2011 | 263.5 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 5.17 Billion CNY | 16.94% |
| 2024 Q2 | 4.88 Billion CNY | -5.53% |
| 2024 Q3 | 8.16 Billion CNY | -8.18% |
| 2023 FY | 4.42 Billion CNY | 3.86% |
| 2023 Q1 | 4.59 Billion CNY | 7.96% |
| 2023 Q3 | 4.6 Billion CNY | -1.08% |
| 2023 Q4 | 4.42 Billion CNY | -3.9% |
| 2023 Q2 | 4.65 Billion CNY | 1.21% |
| 2022 Q4 | 4.25 Billion CNY | -21.23% |
| 2022 Q2 | 5.22 Billion CNY | 8.46% |
| 2022 Q1 | 4.81 Billion CNY | 22.7% |
| 2022 Q3 | 5.4 Billion CNY | 3.51% |
| 2022 FY | 4.25 Billion CNY | 8.51% |
| 2021 FY | 3.92 Billion CNY | 7.97% |
| 2021 Q1 | 4.05 Billion CNY | 11.57% |
| 2021 Q2 | 4.65 Billion CNY | 14.79% |
| 2021 Q3 | 4.55 Billion CNY | -2.07% |
| 2021 Q4 | 3.92 Billion CNY | -13.91% |
| 2020 Q4 | 3.63 Billion CNY | 1.15% |
| 2020 Q1 | 3.36 Billion CNY | 49.53% |
| 2020 FY | 3.63 Billion CNY | 61.28% |
| 2020 Q2 | 3.5 Billion CNY | 4.11% |
| 2020 Q3 | 3.59 Billion CNY | 2.42% |
| 2019 Q2 | 2.93 Billion CNY | 49.27% |
| 2019 FY | 2.25 Billion CNY | 28.45% |
| 2019 Q4 | 2.25 Billion CNY | -21.39% |
| 2019 Q3 | 2.86 Billion CNY | -2.23% |
| 2019 Q1 | 1.96 Billion CNY | 11.98% |
| 2018 Q1 | 1.08 Billion CNY | 73.76% |
| 2018 Q4 | 1.75 Billion CNY | 27.66% |
| 2018 FY | 1.75 Billion CNY | 181.18% |
| 2018 Q3 | 1.37 Billion CNY | 10.45% |
| 2018 Q2 | 1.24 Billion CNY | 14.76% |
| 2017 Q4 | 623.67 Million CNY | -7.83% |
| 2017 FY | 623.67 Million CNY | 137.14% |
| 2017 Q3 | 676.67 Million CNY | 113.68% |
| 2017 Q2 | 316.67 Million CNY | 0.0% |
| 2017 Q1 | 316.67 Million CNY | 20.41% |
| 2016 FY | 263 Million CNY | -61.39% |
| 2016 Q4 | 263 Million CNY | 139.09% |
| 2016 Q2 | 50 Million CNY | -85.29% |
| 2016 Q1 | 340 Million CNY | -50.08% |
| 2016 Q3 | 110 Million CNY | 120.0% |
| 2015 Q2 | 559.04 Million CNY | 16.9% |
| 2015 Q4 | 681.12 Million CNY | 15.94% |
| 2015 Q3 | 587.49 Million CNY | 5.09% |
| 2015 Q1 | 478.22 Million CNY | -24.65% |
| 2015 FY | 681.12 Million CNY | 7.32% |
| 2014 Q1 | - CNY | -100.0% |
| 2014 Q3 | 808.47 Million CNY | 11.8% |
| 2014 Q4 | 634.63 Million CNY | -21.5% |
| 2014 FY | 634.63 Million CNY | 6.59% |
| 2014 Q2 | 723.17 Million CNY | 0.0% |
| 2013 FY | 595.41 Million CNY | 41.05% |
| 2013 Q4 | 595.41 Million CNY | 0.0% |
| 2012 FY | 422.14 Million CNY | 60.2% |
| 2011 FY | 263.5 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| China Meheco Group Co., Ltd. | 7.05 Billion CNY | 37.308% |
| Liaoning Cheng Da Co., Ltd. | 14.02 Billion CNY | 68.487% |
| Shanghai Pharmaceuticals Holding Co., Ltd | 58.55 Billion CNY | 92.45% |